Acura Pharmaceuticals Inc.

Quick facts

Phase 3 pipeline

• Acurox 7.5/30 · Pain Management
  Acurox 7.5/30 is a combination of oxycodone and acetaminophen designed with abuse-deterrent technology to reduce the risk of misuse and overdose.

Phase 2 pipeline

• Vycavert taken first

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Acura Pharmaceuticals Inc. portfolio CI brief
• Acura Pharmaceuticals Inc. pipeline updates RSS